Graft protection in bypass surgery: siRNA-mediated silencing of adhesion molecules

Oligonucleotides

Volumn 19, Issue 1, 2009, Pages 15-21

  Walker, Tobias ^a   Wendel, Hans Peter ^a   Raabe, Claudia ^a   Wiechnik, Patrycja ^a   Spranger, Liane ^a   Heidenreich, Olaf ^c   Scheule, Albertus M ^a   Nordheim, Alfred ^b   Ziemer, Gerhard ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; SMALL INTERFERING RNA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; PRIORITY JOURNAL; RNA INTERFERENCE;

BASE SEQUENCE; CELL ADHESION MOLECULES; CORONARY ARTERY BYPASS; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; RNA, SMALL INTERFERING;

EID: 61349156755     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2008.0148     Document Type: Article

References (17)

1. ALEXANDER, J.H., HAFLEY, G., HARRINGTON, R.A., PETERSON, E.D., FERGUSON, T.B., Jr., LORENZ, T.J., GOYAL A, GIBSON, M., MACK, M.J., GENNEVOIS, D., CALIFF, R.M., KOUCHOUKOS, N.T., and PREVENT IV INVESTIGATORS. (2005). Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA 294, 2446-2454.
2. CONTE, M.S., BANDYK, D.F., CLOWES, A.W., MONETA, G.L., SEELY, L., LORENZ, T.J., NAMINI, H., HAMDAN, A.D., RODDY, S.P., BELKIN, M., BERCELI, S.A., DEMASI, R.J., SAMSON, R.H., BERMAN, S.S., and PREVENT III INVESTIGATORS. (2006). Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J. Vasc. Surg. 43, 742-751.
3. CONTE, M.S., LORENZ, T.J., BANDYK, D.F., CLOWES, A.W., MONETA, G.L., and SEELY, B.L. (2005). Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc. Endovascular Surg. 39, 15-23.
4. ERIKSSON, E.E., KARLOF, E., LUNDMARK, K., ROTZIUS, P., HEDIN, U., and XIE, X. (2005). Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler. Thromb. Vasc. Biol. 25, 723-728.
5. FIRE, A.Z. (2007). Gene silencing by double-stranded RNA (Nobel lecture). Angewandte Chemie-International Edition. 46, 6967-6984.
6. HOPE, S.A., and MEREDITH, I.T. (2003a). Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis. Intern. Med. J. 33, 380-386.
7. HOPE, S.A., and MEREDITH, I.T. (2003b). Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern. Med. J. 33, 450-462.
8. KAISER, C., and PFISTERER, M. (2007). Increased rate of stent thrombosis with DES. Herz. 32, 296-300.
9. KRIEGLSTEIN, C.F., and GRANGER, D.N. (2001). Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 14, 44S-54S.
10. PETRUZZELLI, L., MADUZIA, L., and SPRINGER, T.A. (1998). Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation. J. Immunol. 160, 4208-4216.
11. PFISTERER, M., BRUNNER-LA ROCCA, H.P., BUSER, P.T., RICKENBACHER, P., HUNZIKER, P., MUELLER C, JEGER, R., BADER, F., OSSWALD, S., KAISER, C., and BASKET-LATE INVESTIGATORS. (2006). Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J. Am. Coll. Cardiol. 48, 2584-2591.
12. SCHOMIG, A., DIBRA, A., WINDECKER, S., MEHILLI, J., SUAREZ, D.L., KAISER, C., PARK, S.J., GOY, J.J., LEE, J.H., DI LORENZO, E., WU, J., JÜNI, P., PFISTERER, M.E., MEIER, B., and KASTRATI, A. (2007). A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J. Am. Coll. Cardiol. 50, 1373-1380.
13. SLEDZ, C.A., and WILLIAMS, B.R. (2005). RNA interference in biology and disease. Blood. 106, 787-794.
14. SVOBODA, P. (2007). Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr. Opin. Mol. Ther. 9, 248-257.
15. WALKER, T., WENDEL, H.P., TETZLOFF, L., HEIDENREICH, O., and ZIEMER G. (2005). Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur. J. Cardiothorac. Surg. 28, 816-820.
16. WALKER, T., WENDEL, H.P., TETZLOFF, L., RAABE, C., HEIDENREICH, O., SIMON P, SCHEULE, A.M., and ZIEMER, G. (2007). Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J. Cell. Mol. Med. 11, 139-147.
17. ZHANG, W.D., BAI, H.Z., SAWA, Y., YAMAKAWA, T., KADOBA, K., TANIGUCHI K, MASUDA J, OGATA J, SHIRAKURA, R., and MATSUDA, H. (1999). Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts. J. Vasc. Surg. 30, 169-183.